David T Hickman

USPTO Granted Patents = 13 (Patent Applications = 2)

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 88(Granted Patents)

Location History:

La Tour de Trême, CH (2010)
Strasbourg Cedex, FR (2010 - 2013)
Saint-Sulpice, CH (2014 - 2018)
St-Sulpice, CH (2023 - 2024)

Company Filing History:

Avanti Polar Lipids, Inc.

patents

2 out of 159

Janssen Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11958889 - Compositions of phosphorylated tau peptides and uses thereof (2024-04-16),

2. 11591377 - Heterologous administration of tau vaccines (2023-02-28),

3. 10143744 - Disaccharide synthetic lipid compounds and uses thereof (2018-12-04),

4. 9975946 - Antibodies obtainable using supramolecular constructs (2018-05-22),

5. 9687447 - Method for preparing liposome-based constructs (2017-06-27),

6. 9518078 - Disaccharide synthetic lipid compounds and uses thereof (2016-12-13),

7. 9289488 - Vaccine engineering (2016-03-22),

8. 9241988 - Disaccharide synthetic lipid compounds and uses thereof (2016-01-26),

9. 8926983 - Method for improving memory in AD patients (2015-01-06),

10. 8663650 - Methods and compositions comprising supramolecular constructs (2014-03-04),

11. 8409580 - Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers (2013-04-02),

12. 7807171 - Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers (2010-10-05),

13. 7772375 - Monoclonal antibodies that recognize epitopes of amyloid-beta (2010-08-10),

Title: The Innovations of David T Hickman

Introduction

David T Hickman is a notable inventor based in Saint-Sulpice, Switzerland. He has made significant contributions to the field of neurodegenerative disease research, particularly in relation to Alzheimer's Disease. With a total of 13 patents to his name, Hickman's work focuses on innovative therapeutic approaches that aim to combat these debilitating conditions.

Latest Patents

Hickman's latest patents include groundbreaking compositions of phosphorylated tau peptides and their uses. One of his notable inventions describes liposomes containing tau peptides, specifically phosphorylated tau peptides, and conjugates that are linked to an immunogenic carrier. These pharmaceutical compositions are designed for treating or preventing neurodegenerative diseases, including Alzheimer's Disease. Another significant patent outlines methods for inducing an immune response against tau protein in individuals suffering from neurodegenerative disorders. This method involves administering a liposomal priming composition along with a conjugate boosting composition, both containing tau peptides.

Career Highlights

Throughout his career, David T Hickman has worked with prominent companies in the biotechnology sector. He has been associated with Ac Immune SA and Avanti Polar Lipids, Inc., where he has contributed to the advancement of research in neurodegenerative diseases. His expertise and innovative approaches have positioned him as a key figure in this critical area of medical research.

Collaborations

Hickman has collaborated with esteemed colleagues, including Andreas Muhs and Ruth Greferath. These partnerships have further enhanced his research efforts and have contributed to the development of effective therapeutic strategies.

Conclusion

David T Hickman is a distinguished inventor whose work in the field of neurodegenerative diseases has the potential to make a significant impact on treatment options for conditions like Alzheimer's Disease. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.